Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (88 ops.)
Latest filing published 09 Sept 2026 for Tarsus Pharmaceuticals, Inc., €552k.
Filing timeline
BuySaleBobak R. Azamian
Insider track record
Disclosed buys
0
Disclosed sells
88
Signal history
Bobak R. Azamian: trading record in brief
Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc., filed 95 reports between October 20, 2020 and September 9, 2026, nearly all sales: 88 sales worth EUR 13.5 million, with a median of EUR 95,223. The largest, EUR 1,783,549, is dated July 19, 2023. Two others, EUR 699,193 and EUR 694,693, follow each other on March 18, 2026 and March 19, 2026. No purchase; 4 option exercises and 3 filings of another nature complete the record, with no grant.
The yearly split is contrasted: 40 filings in 2023, 17 in 2021, 15 in 2022, but 2 in 2024. Over the last twelve months: 12 filings, 10 of them sales.
The median publication delay is 2 days. At Tarsus, 46 of Azamian's trades fall within 30 days of a trade by Aziz Mottiwala, 39 of Leonard M. Greenstein, 34 of Dianne C. Whitfield and 32 of Bryan Wahl, all in the same direction.
Companies and markets linked to Bobak R. Azamian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations95 total
7,100 shares@ US$90.270.019% mcap4.1% of flowCommon StockSEC:0001827672-26-000013:0
2,900 shares@ US$91.270.0079% mcap1.7% of flowCommon StockSEC:0001827672-26-000013:1
10,000 shares@ US$80.060.023% mcap9.0% of flowCommon StockSEC:0001827672-26-000011:0
4,582 shares@ US$61.243.0% of flowCommon StockSEC:0001827672-26-000009:0
5,418 shares@ US$61.813.5% of flowCommon StockSEC:0001827672-26-000009:1
11,667 shares@ US$68.715.2% of flowCommon StockSEC:0001827672-26-000007:1
11,964 shares@ US$67.005.2% of flowCommon StockSEC:0001827672-26-000007:2
10,972 shares@ US$69.428.6% of flowCommon StockSEC:0001827672-26-000007:0
66,274 sharesCommon StockSEC:0001827672-26-000005:0
557 shares@ US$83.540.5% of flowCommon StockSEC:0001827672-25-000007:1
5,443 shares@ US$82.415.0% of flowCommon StockSEC:0001827672-25-000007:0
51,885 shares0Common StockSEC:0001827672-25-000005:0
6,000 shares@ US$55.373.7% of flowCommon StockSEC:0001827672-25-000003:0
6,000 shares@ US$50.003.4% of flowCommon StockSEC:0001819790-25-000110:0
6,000 shares@ US$50.003.6% of flowCommon StockSEC:0001819790-25-000061:0
8,551 shares@ US$47.402.7% of flowCommon StockSEC:0001819790-25-000055:1
8,534 shares@ US$50.112.9% of flowCommon StockSEC:0001819790-25-000055:2
7,131 shares@ US$46.293.9% of flowCommon StockSEC:0001819790-25-000055:0
51,395 sharesCommon StockSEC:0001819790-25-000046:0
10,415 shares@ US$30.602.2% of flowCommon StockSEC:0001819790-24-000045:1
28,274 sharesCommon StockSEC:0001819790-24-000045:0
8,000 shares@ US$20.221.9% of flowCommon StockSEC:0001827672-23-000050:0
30,557 shares@ US$20.364.2% of flowCommon StockSEC:0001827672-23-000048:1
9,443 shares@ US$19.962.2% of flowCommon StockSEC:0001827672-23-000048:0
4,904 shares@ US$18.540.6% of flowCommon StockSEC:0001827672-23-000045:1
25 of 95 declarations
